OIOrhan Ince

Orhan Ince

*This is an algorithmically generated author record based on publicly available information.

Orhan Ince has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Ertugrul Okuyan

    Department of Cardiology, Istanbul Bagcilar Training and Research Hospital

    2 shared publications
  • Esra Donmez

    Department of Cardiology, Istanbul Bagcilar Training and Research Hospital

    2 shared publications
  • Irfan Sahin

    Department of Cardiology, Istanbul Bagcilar Training and Research Hospital

    2 shared publications
  • Kamil Gulsen

    Department of Cardiology, Health and Science University Kartal Kosuyolu Training and Research Hospital, Istanbul

    2 shared publications
  • Sevgi Ozcan

    Department of Cardiology, Istanbul Bagcilar Training and Research Hospital

    2 shared publications
  • Alper Kepez

    Department of Cardiology, Marmara University Faculty of Medicine, Istanbul, Turkey

    1 shared publication

Latest Publications

  • Open Access

    Predictive Value of R2CHA2DS2-VA Score for 90-Day Functional Outcomes After Endovascular Thrombectomy in Acute Ischemic Stroke

    by Faruk Boyacı, Cetin Kursad Akpınar, Mustafa Kursat Sahin, Murat Akcay, Hasan Dogan, Mustafa Yenercag, Guney Erdogan, Berkant Ozturk, Yankı Boyacı, Orhan Ince

    Background and Objectives: Endovascular treatment (EVT) has been shown to enhance long-term recovery and lower mortality rates in patients with intracranial large vessel occlusion-associated acute ischemic strokes (AISs).We aimed to evaluate the predictive value of the pre-stroke CHA2DS2-VA, R2CHA2DS2-VA, CHA2DS2-VASc, and R2CHA2DS2-VASc scores in determining 90-day functional outcomes based on the modified Rankin Scale (mRS). Methods: In a single center between 2018 and 2023, 665 AIS patients who underwent EVT and achieved successful reperfusion were screened retrospectively. After inclusion and exclusion criteria, 583 patients were included. Based on 90-day mRS scores, patients were classified into two groups: good (mRS ≤ 2, n = 257) and poor functional outcomes (mRS 3–6, n = 326). The pre-stroke scores were calculated. Results: When ROC curve analysis was performed, R2CHA2DS2-VA demonstrated the highest AUC value (p = 0.0443) among these scores. The optimal cutoff score was determined to be 4, yielding a sensitivity of 75.77% and specificity of 93.39%. In multivariable analysis, a higher R2CHA2DS2-VA score was significantly associated with worse outcomes (OR = 1.637, 95%, CI: 2.436–5.510, p < 0.001). A longer onset-to-recanalization time (OR = 1.009, 95%, CI: 1.005–1.014, p < 0.001) and presence of hyperlipidemia (OR = 2.960, 95%, CI: 1.254–6.988, p = 0.01) were correlated with poor prognosis. Higher baseline NIHSS scores were associated with unfavorable outcomes (OR = 1.201, 95%, CI: 1.014–1.422, p = 0.034), and this association remained significant for NIHSS scores measured 24 h post-EVT (OR = 1.467, 95%, CI: 1.230–1.748, p < 0.001). Conclusions: The R2CHA2DS2-VA score demonstrates superior predictive ability for 90-day functional outcomes in AIS patients treated with EVT, surpassing CHA2DS2-VASc and similar scoring systems.


  • Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?

    by Orhan Ince, Kamil Gulsen, Sevgi Ozcan, Esra Donmez, Murat Ziyrek, Irfan Sahin, Ertugrul Okuyan

    Aortic valve stenosis (AS) is the most common valvular disease, and surgical or transcatheter aortic valve replacement (TAVR) are the treatment options. Diminish in platelet production or dysfunction may occur due to shear stress, advanced age, and other coexisting diseases in AS patients. Bleeding is one of the complications of TAVR and associated with increased mortality. MPV (mean platelet volume) indicates platelet's thrombogenic activity. Overproduction or consumption of platelets in various cardiac conditions may affect MPV values. We aimed to investigate the pre and postprocedure MPV percentage change (MPV-PC) and its association with post-TAVR short-term complications. A total of 204 patients who underwent TAVR with a diagnosis of severe symptomatic AS were included. The mean age was 78.66 ± 6.45 years, and 49.5% of patients were women. Two groups generated according to composite end point (CEP) development: CEP(+) and CEP(-).110 patients(53.9%) formed CEP(+) group. Although baseline MPV and platelet levels were similar between groups, MPV was increased (P < 0.001) and platelet was decreased (P < 0.001) significantly following the procedure when compared to baseline. MPV-PC was significantly higher in the VARC type 2–4 bleeding (P = 0.036) and major vascular, access-related, or cardiac structural complication groups (P = 0.048) when CEP subgroups were analyzed individually. Regression analysis revealed that diabetes mellitus [P = 0.044, β: 1.806 odds ratio (95% confidence interval): 1.016–3.21] and MPV-PC [P = 0.007,β: 1.044 odds ratio (95% confidence interval): 1.012–1.077] as independent predictors of CEP development at 1 month after TAVR. The MPV increase following TAVR may be an indicator of adverse outcomes following TAVR procedure within 1-month.

  • Positive blood pressure response may predict the recovery of renal function after transcatheter aortic valve implantation

    by Orhan Ince, Kamil Gulsen, Sevgi Ozcan, Sevil Tugrul, Fahrettin Katkat, Serkan Karahan, Esra Donmez, Alper Kepez, Irfan Sahin, Ertugrul Okuyan

    Objective: Transcatheter aortic valve implantation (TAVI) may ameliorate renal function and increase blood pressure (BP). We aimed to investigate the association between increased BP and improved renal function (IRF) after TAVI. Methods: A total of 176 patients who had undergone TAVI were evaluated retrospectively. BP records that were taken 24 h before and 72 h after TAVI were reviewed. Pre-procedural, post-procedural 48 h, and the first month estimated glomerular filtration rate (eGFR) levels were noted. IRF was accepted as a ≥ 10% increase in eGFR. The predictors of acute kidney injury (AKI) development at 48 h and IRF at 1 month were investigated. The association between mortality and BP response was assessed. Results: A total of 157 patients were included in this study after exclusion as defined in the methodology. Mean age was 78.1 ± 7,1 and 51.6% were female. AKI occurred in 25.5% of patients and baseline eGFR and male gender were found as independent predictors for AKI development. IRF was observed in 16% at 48 h and 31.8% of patients at 1-month follow-up. Positive BP response was seen in 42% of patients. Pre-procedural chronic kidney disease, positive BP response, and an early increase in eGFR emerged as independent predictors of IRF at the first month. The patients with positive BP response were found to have decreased mortality at 710 days follow-up. Conclusion: Positive BP response after TAVI is related to improved survival and renal functions. The beneficial effect of TAVI on renal function may be precisely evaluated at 1st month rather than 48 h.